Transcriptomic Changes Associated with ERBB2 Overexpression in Colorectal Cancer Implicate a Potential Role of the Wnt Signaling Pathway in Tumorigenesis

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal Cancer

(2022) John H. Strickler et al.   JAMA Oncology

SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer

(2022) Yonghui Liu et al.   Cell Death Discovery

snoRNAs: functions and mechanisms in biological processes, and roles in tumor pathophysiology

(2022) Zheng-hao Huang et al.   Cell Death Discovery

Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

(2022) Hui Zhao et al.   Molecular Cancer

Targeting HER2-positive breast cancer: advances and future directions

(2022) Sandra M. Swain et al.   NATURE REVIEWS DRUG DISCOVERY

Prolonged Response to HER2‐Directed Therapy in Three Patients with HER2‐Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the Literature

(2021) Michael May et al.   ONCOLOGIST

Nkx2.5 Functions as a Conditional Tumor Suppressor Gene in Colorectal Cancer Cells via Acting as a Transcriptional Coactivator in p53-Mediated p21 Expression

(2021) Huili Li et al.   Frontiers in Oncology

lncENST Suppress the Warburg Effect Regulating the Tumor Progress by the Nkx2-5/ErbB2 Axis in Hepatocellular Carcinoma

(2021) Geng Chen et al.   Computational and Mathematical Methods in Medicine

Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer

(2020) Huizhe Wu et al.   Molecular Cancer

Small Nucleolar RNAs: Insight Into Their Function in Cancer

(2019) Junnan Liang et al.   Frontiers in Oncology

HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells

(2019) Da Hyun Jung et al.   ONCOLOGY

Assessment of two different HER2 scoring systems and clinical relevance for colorectal cancer

(2019) Furong Liu et al.   VIRCHOWS ARCHIV

NKX2.5 is expressed in papillary thyroid carcinomas and regulates differentiation in thyroid cells

(2018) Ricardo Cortez Cardoso Penha et al.   BMC CANCER

Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression

(2018) Hayley Pye et al.   Oncotarget

Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology

(2018) John Marquart et al.   JAMA Oncology

SNORA21 – An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer

(2017) Kazuhiro Yoshida et al.   EBioMedicine

Perspective: The precision-oncology illusion

(2016) Vinay Prasad   NATURE

Genetics of Congenital Heart Defects: The NKX2-5 Gene, a Key Player

(2016) Ill-Min Chung et al.   Genes

Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms

(2016) Maria Schwaederle et al.   JAMA Oncology

Global Cancer Incidence and Mortality Rates and Trends--An Update

(2015) L. A. Torre et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

(2015) Funda Meric-Bernstam et al.   JOURNAL OF CLINICAL ONCOLOGY

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation

(2015) Po-Ming Chen et al.   Oncotarget

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification

(2015) Charlotte KY Ng et al.   GENOME BIOLOGY

Nkx2-5 regulates cardiac growth through modulation of Wnt signaling by R-spondin3

(2014) L. Cambier et al.   DEVELOPMENT

Whole genome DNA methylation signature of HER2-positive breast cancer

(2014) Breezy M Lindqvist et al.   Epigenetics

LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas

(2013) L-H Tsai et al.   ONCOGENE

Exploring single-sample SNP and INDEL calling with whole-genome de novo assembly

(2012) H. Li   BIOINFORMATICS

Suppression of lung adenocarcinoma progression by Nkx2-1

(2011) Monte M. Winslow et al.   NATURE

The Role of Nkx2.5 in Keratinocyte Differentiation

(2010) Chul Hwang et al.   Annals of Dermatology

Targeting Wnt Signaling in Colon Cancer Stem Cells

(2010) E. M. F. de Sousa et al.   CLINICAL CANCER RESEARCH

Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism

(2010) R A Hamoudi et al.   LEUKEMIA

TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI

(2010) Arindam Chaudhury et al.   NATURE CELL BIOLOGY

A Robust Automated Measure of Average Antibody Staining in Immunohistochemistry Images

(2009) Kingshuk Roy Choudhury et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Establishment and Characterization of an Ovarian Yolk Sac Tumor Cell Line Reveals Possible Involvement of Nkx2.5 in Tumor Development

(2008) Kiyosumi Shibata et al.   ONCOLOGY